Nanjing Vazyme Biotech Co., Ltd. Class ASSE: 688105

Announcement on the Proposed Change in the Use of Partial Raised Funds and the Permanent Supplement of Working Capital with Partial Excess Raised Funds

· Issued by Nanjing Vazyme Biotech Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Proposed Change in the Use of Partial Raised Funds and the Permanent Supplement of Working Capital with Partial Excess Raised Funds

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis